Literature DB >> 7350241

Reassessment of the evidence for the role of secreted ADP in biphasic platelet aggregation. Mechanism of inhibition by creatine phosphate plus creatine phosphokinase.

E M Huang, T C Detwiler.   

Abstract

The observation that platelet secretion occurs in parallel with the second wave of platelet aggregation necessitates reassessment of the generally accepted concept that secreted ADP is the cause of second-wave aggregation. The major evidence for an involvement of secreted ADP is inhibition of second-wave aggregation by enzyme-catalyzed removal of ADP, interpreted as removal of secreted ADP. An alternative hypotheses, that the observed inhibition is due to a decrease in potentiation by extracellular ADP present prior to addition of stimulus, has been tested with the enzyme system CP plus CPK (CP/CPK). Low levels of CP/CPK inhibited gamma-thrombin-induced second-wave aggregation only after preincubation. When the second wave of gamma-thrombin- or epinephrine-induced aggregation was inhibited by very high levels of CP/CPK, the inhibition was overcome by an increase in the level of stimulus. These results are inconsistent with the idea that CP/CPK blocks second-wave aggregation by removing secreted ADP, but they are consistent with a decreased potentiation of the platelets due to a lower level of extracellular ADP prior to stimulation. Freshly prepared platelet-rich plasma contained a mean (n = 16) of 12 nM extracellular ADP. These data demonstrate that inhibition by CP/CPK cannot be taken as evidence for the involvement of secreted ADP.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7350241

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  8 in total

1.  Biochemical mechanisms in 5-hydroxytryptamine-induced human platelet aggregation.

Authors:  F de Clerck; B Xhonneux; R van de Wiele
Journal:  Agents Actions       Date:  1985-12

2.  Ultrastructural physiology of platelets with randomly dispersed rather than circumferential band microtubules.

Authors:  J G White
Journal:  Am J Pathol       Date:  1983-01       Impact factor: 4.307

3.  Thrombin-induced phosphoinositide hydrolysis in platelets. Receptor occupancy and desensitization.

Authors:  E M Huang; T C Detwiler
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

Review 4.  Characteristics of an ADP receptor mediating platelet activation.

Authors:  R W Colman; W R Figures
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

5.  Influence of a microtubule stabilizing agent on platelet structural physiology.

Authors:  J G White; G H Rao
Journal:  Am J Pathol       Date:  1983-08       Impact factor: 4.307

6.  Contribution of ADP to the amplification of primary platelet aggregation by platelet activating factor (PAF): modulatory role of aspirin.

Authors:  D Lauri; C Cerletti; G de Gaetano
Journal:  Agents Actions       Date:  1986-03

7.  A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.

Authors:  J S Bennett; G Vilaire; J W Burch
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets.

Authors:  G P Lewis; I S Watts
Journal:  Br J Pharmacol       Date:  1982-04       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.